Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

JNJ

Johnson & Johnson

Nov 08 • 04:00PM ET

155.47

Dollar change -1.26
Percentage change -0.80	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: LLY PFE MRK AMGN BMY NVS ABBV GSK AZN MDT

| Held by: VTI VOO SPY IVV VTV XLV VIG VYM QUAL VHT

Scroll to Statements

Index	DJIA, S&P 500	P/E	25.70	EPS (ttm)	6.05	Insider Own	0.12%	Shs Outstand	2.41B	Perf Week	-2.91%
Market Cap	371.30B	Forward P/E	14.69	EPS next Y	10.59	Insider Trans	-0.20%	Shs Float	2.40B	Perf Month	-3.14%
Income	14.68B	PEG	5.35	EPS next Q	2.02	Inst Own	72.39%	Short Float	0.78%	Perf Quarter	-2.76%
Sales	87.69B	P/S	4.23	EPS this Y	0.30%	Inst Trans	1.87%	Short Ratio	3.09	Perf Half Y	3.71%
Book/sh	29.14	P/B	5.33	EPS next Y	6.40%	ROA	8.58%	Short Interest	18.66M	Perf Year	3.41%
Cash/sh	8.50	P/C	18.29	EPS next 5Y	4.80%	ROE	20.89%	52W Range	143.13 - 168.85	Perf YTD	-0.81%
Dividend Est.	4.68 (3.01%)	P/FCF	17.90	EPS past 5Y	-0.27%	ROI	14.47%	52W High	-7.92%	Beta	0.51
Dividend TTM	4.86 (3.13%)	Quick Ratio	0.79	Sales past 5Y	1.31%	Gross Margin	68.67%	52W Low	8.62%	ATR (14)	2.19
Dividend Ex-Date	Nov 26, 2024	Current Ratio	1.03	EPS Y/Y TTM	15.10%	Oper. Margin	24.60%	RSI (14)	30.77	Volatility	1.51% 1.46%
Employees	131900	Debt/Eq	0.51	Sales Y/Y TTM	-8.03%	Profit Margin	16.75%	Recom	2.18	Target Price	176.22
Option/Short	Yes / Yes	LT Debt/Eq	0.45	EPS Q/Q	-43.91%	Payout	84.93%	Rel Volume	1.46	Prev Close	156.73
Sales Surprise	1.35%	EPS Surprise	9.68%	Sales Q/Q	5.27%	Earnings	Oct 15 BMO	Avg Volume	6.04M	Price	155.47
SMA20	-3.59%	SMA50	-4.39%	SMA200	-0.37%	Trades		Volume	8,818,525	Change	-0.80%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-23-24	Downgrade	Daiwa Securities	Outperform → Neutral	$160 → $150
May-30-24	Resumed	Goldman	Neutral	$160
Apr-18-24	Upgrade	HSBC Securities	Hold → Buy	$170
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$170 → $163
Dec-01-23	Upgrade	UBS	Neutral → Buy	$167 → $180
Oct-05-23	Initiated	RBC Capital Mkts	Outperform	$178
Sep-06-23	Initiated	HSBC Securities	Hold	$175
May-30-23	Resumed	Citigroup	Buy	$185
Mar-29-23	Initiated	UBS	Neutral	$164
Mar-01-23	Initiated	Guggenheim	Neutral	$161
Nov-18-22	Initiated	Credit Suisse	Neutral	$170
Oct-18-22	Initiated	Barclays	Equal Weight	$175
Oct-14-22	Reiterated	BofA Securities	Neutral	$185 → $178
Jun-22-22	Initiated	Daiwa Securities	Outperform
May-23-22	Resumed	SVB Leerink	Outperform	$200
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$173
Mar-16-22	Downgrade	Bernstein	Outperform → Mkt Perform	$180 → $183
Mar-02-22	Resumed	BofA Securities	Neutral	$185
Dec-17-21	Initiated	Goldman	Neutral	$161
Dec-15-21	Reiterated	Citigroup	Buy	$192 → $195

Show Previous Ratings

Nov-08-24 10:38AM	Why Johnson & Johnson (JNJ)s Legal Issues Could Wrap Up Quickly (Insider Monkey)
09:35AM	Analyst Report: Johnson & Johnson (Morningstar Research)
07:00AM	Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO / DARZALEX as subcutaneous monotherapy for high-risk smoldering multiple myeloma (PR Newswire)
05:27AM	Johnson & Johnson MedTechs VARIPULSE Platform receives FDA approval for AFib (Medical Device Network)
04:15AM	Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever (Motley Fool)
02:46PM	Loading…
Nov-07-24 02:46PM	FDA Greenlights J&J's Varipulse Device for Safer Atrial Fibrillation Treatment (GuruFocus.com)
08:00AM	Johnson & Johnson advances leadership in rheumatic disease innovation with 43 abstracts at ACR 2024 (PR Newswire)
06:35AM	J&J wins FDA approval for Varipulse PFA system (MedTech Dive)
Nov-05-24 09:00AM	Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Nov-04-24 06:35PM	Is Johnson & Johnson (JNJ) the Best Pharma Stock to Buy Right Now? (Insider Monkey)
03:11PM	Empower 2024 Delivers Groundbreaking Insights and Innovation to Achieve Data-Driven Healthcare (GlobeNewswire)
Nov-01-24 08:35AM	Johnson & Johnson MedTech concludes enrolment for OMNY-AF trial pilot phase (Medical Device Network)
07:47AM	J&J Medtech CIO Larry Jones resigns (MedTech Dive)
Oct-31-24 04:00AM	Psoriasis biosimilars and pricing changes herald treatment paradigm disruptions (Pharmaceutical Technology)
Oct-29-24 09:19AM	J&J and Lilly both unveil IL-23 inhibitor efficacy in Crohns disease (Clinical Trials Arena)
09:19AM	Loading…
09:19AM	J&J and Lilly both boast IL-23 inhibitor efficacy in Crohns disease (Clinical Trials Arena)
08:00AM	Invest with Confidence: Intrinsic Value Unveiled of Johnson & Johnson (GuruFocus.com)
06:32AM	J&J to seek FDA approval after small-bore Impella heart pump hits trial goal (MedTech Dive)
Oct-28-24 12:33PM	J&Js $8.2 Billion Talc Settlement Faces January Court Test (Bloomberg)
12:09PM	AbbVie to Acquire Aliada Therapeutics for $1.4 Billion (The Wall Street Journal)
11:32AM	Johnson & Johnson's Tremfya Seeks Expanded Use Approval After It Shares Encouraging Late-Stage Study Data In Crohn's Disease (Benzinga)
07:30AM	TREMFYA (guselkumab) is the first and only IL-23 inhibitor to demonstrate robust results with a fully subcutaneous regimen in both induction and maintenance in Crohn's disease (PR Newswire)
Oct-27-24 12:16PM	3 Dividend Stocks to Double Up on Right Now (Motley Fool)
Oct-26-24 07:30AM	3 Dividend Growth Stocks You Can Buy and Hold Forever (Motley Fool)
Oct-25-24 01:19PM	Johnson & Johnson's Blockbuster Drug Tremfya Clears Plaque Psoriasis With Lesions Covering Body's Smaller Areas (Benzinga)
08:05AM	New SPECTREM study findings reveal TREMFYA (guselkumab) effectively clears overlooked and undertreated plaque psoriasis (PR Newswire)
05:37AM	Is Kenvue Stock a Buy Now? (Motley Fool)
Oct-24-24 01:28PM	Johnson & Johnson (JNJ): Legal Challenges Over Talc Products Impact Dow Performance (Insider Monkey)
10:26AM	Johnson & Johnson Investing $2B to Build Pharma Factory in North Carolina (Design & Development Today)
08:00AM	If You Invested $10,000 In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now? (Benzinga)
08:00AM	Loading…
08:00AM	Johnson & Johnson highlights innovative neuropsychiatry portfolio and pipeline at Psych Congress (PR Newswire)
05:21AM	Meet the Only 2 Game-Changing Businesses With a Higher Credit Rating Than the U.S. Government (Motley Fool)
04:00AM	J&Js Asish Xavier on biotechs rebound in a volatile era (BioPharma Dive)
01:02AM	Decoding Johnson & Johnson (JNJ): A Strategic SWOT Insight (GuruFocus.com)
Oct-23-24 05:03PM	J&Js Darzalex combination gains expanded label for multiple myeloma in Europe (Pharmaceutical Technology)
09:00AM	Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know (Zacks)
04:30AM	This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lilly's Stock (Motley Fool)
Oct-22-24 01:13AM	Boston Scientific, Edwards and Dexcom usher in second week of earnings (MedTech Dive)
Oct-21-24 05:03PM	S&P 500 Gains and Losses Today: Housing Stocks Fall as Rate-Cut Outlook Softens (Investopedia)
03:33PM	Stocks trading lower: Boeing, Kenvue, ASML, and more are big movers (TheStreet)
11:26AM	Starboard Value Buys Into Dow Jones Spinoff; ELF Beauty Rallies (Investor's Business Daily)
10:47AM	Kenvue: Starboard Pushes for a Bold Turnaround (GuruFocus.com)
09:57AM	Tylenol Maker Kenvue Stock Surges on Report Starboard Takes 'Sizable Stake' (Investopedia)
05:30AM	J&Js Ketamine-Derived Drug Is Taking Off (The Wall Street Journal)
Oct-20-24 11:00AM	The 'Texas two-step' is back as J&J tries to shed talc lawsuits for a third time (Yahoo Finance)
Oct-19-24 05:40PM	All It Takes Is $2,500 Invested in Each of These 3 High-Yield Dow Dividend Stocks to Help Generate Over $300 in Passive Income Per Year (Motley Fool)
09:57AM	Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever (Motley Fool)
Oct-18-24 03:25PM	Johnson & Johnson (JNJ): Growth Prospects Enhanced by Key Acquisitions and Approvals (Insider Monkey)
02:34PM	BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug (Benzinga)
08:27AM	Boston Scientific stock down as Needham cuts to Hold on growth concerns (Investing.com)
05:10AM	3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now (Motley Fool)
Oct-17-24 08:18AM	Johnson & Johnson price target raised to $181 from $178 at RBC Capital (TipRanks)
04:14AM	This Magnificent Dividend Stock Is as Healthy as It Gets (Motley Fool)
Oct-16-24 04:04PM	J&J trims neuroscience pipeline seltorexant in Alzheimers disease dropped (Pharmaceutical Technology)
02:31PM	Johnson & Johnson's MedTech Challenges Loom Amid Chinese Market Pressures And Orthopedics Overhaul, Analysts Say (Benzinga)
11:48AM	J&J makes surgical robotic moves with Ottava FDA IDE application (Medical Device Network)
05:27AM	Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold? (Motley Fool)
03:00AM	Johnson & Johnson (JNJ) Q3 2024 Earnings Call Highlights: Strong Sales Growth Amidst ... (GuruFocus.com)
12:41AM	Q3 2024 Johnson & Johnson Earnings Call (Thomson Reuters StreetEvents)
Oct-15-24 07:05PM	Connecticut Jury Delivers $15 Million Asbestos Verdict Against Johnson & Johnson (Business Wire)
06:08PM	Deloitte, Johnson & Johnson execs say people arent using their health benefits until they are in crisis (Fortune)
06:06PM	Asian Stocks to Track US Selloff as Tech Slumps: Markets Wrap (Bloomberg)
04:07PM	J&J Stock Leapfrogs 50-Day Line After Health Care Titan Raises Sales Outlook (Investor's Business Daily)
04:06PM	UnitedHealth, Walgreens, J&J: Health earnings in focus (Yahoo Finance Video)
03:45PM	J&J must pay $15 million to man who says its talc caused his cancer, jury finds (Reuters)
03:26PM	Cancer Drugs Propel J&J Beyond Wall Street Estimates (Benzinga)
02:30PM	Johnson & Johnson (JNJ) Q3 2024 Earnings Call Transcript (Motley Fool)
01:39PM	Jim Cramer Says Is It The Beginning Of The End Of Johnson & Johnson (JNJ)s Multi-Year Legal overhang? Could Be (Insider Monkey)
12:46PM	This is the 3-point checklist for healthcare earnings: Strategist (Yahoo Finance Video)
11:39AM	Analyst Report: Johnson & Johnson (Morningstar Research)
11:07AM	Stocks to Watch Tuesday: J&J, United Health, Apple, Walgreens (The Wall Street Journal)
10:56AM	J&J Reports Strong Earnings, Grapples with Ongoing Legal Challenges (GuruFocus.com)
10:09AM	Johnson & Johnson Stock Rises on Better-Than-Expected Revenue, Adjusted Profit (Investopedia)
10:09AM	Johnson & Johnson Posts Weaker-Than-Expected Profit on Billions in Legal Costs (Investopedia)
09:41AM	J&J Earnings Beat Expectations, Aided by Prescription-Drug Sales (The Wall Street Journal)
09:30AM	Johnson & Johnson (JNJ) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
08:20AM	Johnson & Johnson's Q3 Earnings: Revenue And EPS Beat On Strong Cancer Drug Sales, Revises Annual Outlook To Reflect V-Wave Acquisition (Benzinga)
08:09AM	J&J Reports Strong Earnings but Talc Worries Remain. The Stock Falls. (Barrons.com)
08:03AM	Johnson & Johnson Earnings Top; Dow Giant Falls Amid Lowered Outlook (Investor's Business Daily)
08:00AM	Invest with Confidence: Intrinsic Value Unveiled of Johnson & Johnson (GuruFocus.com)
08:00AM	Nipocalimab demonstrates sustained disease control in adolescents living with generalized myasthenia gravis in Phase 2/3 study (PR Newswire)
07:35AM	Johnson & Johnson (JNJ) Tops Q3 Earnings and Revenue Estimates (Zacks)
07:11AM	Johnson & Johnson reports Q3 beat, raises sales guidance (Investing.com)
06:32AM	Johnson & Johnson: Q3 Earnings Snapshot (Associated Press Finance)
06:25AM	Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024 (Business Wire)
06:22AM	J&J lifts profit and sales forecasts, beats Wall Street expectations (Reuters)
06:20AM	Johnson & Johnson Reports Q3 2024 Results (Business Wire)
Oct-14-24 05:32PM	How to play biotech stocks: Johnson & Johnson, Pfizer (Yahoo Finance Video)
05:15PM	Bank of America, Q3 earnings, Fedspeak: What to Watch (Yahoo Finance Video)
10:49AM	More Patients On Eli Lilly's Mirikizumab Achieved Histologic Response At One Year Compared To Johnson & Johnson's Drug (Benzinga)
08:27AM	Is Johnson & Johnson (JNJ) Stock Set for Further Gains? (Insider Monkey)
06:00AM	J&J, Abbott and Intuitive kick off latest medtech earnings season (MedTech Dive)
Oct-13-24 06:00AM	What To Expect in the Markets This Week (Investopedia)
Oct-12-24 05:40AM	There Are Only 28 S&P 500 Companies Warren Buffett Can't Buy Outright. Here's the Best of the Bunch for Income Investors. (Motley Fool)
Oct-11-24 04:57PM	Netflix earnings, retail rales data, Fedspeak: What to watch (Yahoo Finance Video)
11:53AM	J&Js Court-Shopping Win Highlights Irresistible Bankruptcy Tool (Bloomberg)
10:48AM	XtalPis AI biologics discovery platform licensed to Janssen Biotech (Pharmaceutical Technology)
07:23AM	Sanofi in Talks to Sell Controlling Stake in Consumer Health Arm to CD&R (The Wall Street Journal)
05:00AM	What You Need To Know Ahead of Johnson & Johnson's Earnings (Investopedia)
Oct-10-24 07:39PM	Is Johnson & Johnson (NYSE:JNJ) The Most Popular Stock Among Mutual Funds According To Goldman Sachs? (Insider Monkey)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Decker Robert J	VP Corporate Controller	Aug 30 '24	Option Exercise	100.06	5,635	563,838	24,608	Sep 03 04:48 PM
Decker Robert J	VP Corporate Controller	Aug 30 '24	Sale	165.06	5,635	930,113	18,973	Sep 03 04:48 PM
Decker Robert J	Officer	Aug 30 '24	Proposed Sale	165.06	5,635	930,113		Aug 30 03:51 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Jul 08 '24	Option Exercise	0.00	9,809	0	24,852	Jul 09 05:48 PM
REED JOHN C	EVP, Innovative Medicine, R&D	May 01 '24	Option Exercise	0.00	22,255	0	22,561	May 03 04:31 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Mar 13 '24	Sale	162.16	8,891	1,441,765	15,043	Mar 13 04:36 PM
JOHNSON & JOHNSON	10% Owner	Feb 29 '24	Option Exercise	0.72	3,855	2,792	4,103,430	Mar 06 03:42 PM
JOHNSON & JOHNSON	10% Owner	Feb 16 '24	Sale	25.81	3,725	96,142	4,099,575	Mar 06 03:42 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 13 '24	Option Exercise	0.00	651	0	82,599	Feb 15 04:53 PM
Wolk Joseph J	Exec VP, CFO	Feb 13 '24	Option Exercise	0.00	1,780	0	69,663	Feb 15 04:53 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 13 '24	Option Exercise	0.00	1,302	0	155,517	Feb 15 04:53 PM
Swanson James D.	EVP, CIO	Feb 13 '24	Option Exercise	0.00	447	0	14,765	Feb 15 04:53 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 13 '24	Option Exercise	0.00	499	0	13,290	Feb 15 04:53 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 13 '24	Option Exercise	0.00	925	0	112,550	Feb 15 04:53 PM
Hait William	See Remarks	Feb 13 '24	Option Exercise	0.00	834	0	39,074	Feb 15 04:53 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 13 '24	Option Exercise	0.00	3,470	0	364,809	Feb 15 04:53 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 13 '24	Option Exercise	0.00	408	0	24,143	Feb 15 04:53 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 13 '24	Option Exercise	0.00	651	0	8,576	Feb 15 04:53 PM
Decker Robert J	VP Corporate Controller	Feb 13 '24	Option Exercise	0.00	313	0	19,059	Feb 15 04:53 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 12 '24	Option Exercise	0.00	4,701	0	25,081	Feb 14 06:36 PM
Hait William	See Remarks	Feb 12 '24	Option Exercise	0.00	8,932	0	42,316	Feb 14 06:36 PM
Wolk Joseph J	Exec VP, CFO	Feb 12 '24	Option Exercise	0.00	25,835	0	78,699	Feb 14 06:36 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 12 '24	Option Exercise	0.00	2,859	0	8,959	Feb 14 06:36 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 12 '24	Option Exercise	0.00	26,202	0	167,618	Feb 14 06:36 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 12 '24	Option Exercise	0.00	14,960	0	118,644	Feb 14 06:36 PM
Swanson James D.	EVP, CIO	Feb 12 '24	Option Exercise	0.00	5,456	0	16,013	Feb 14 06:36 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 12 '24	Option Exercise	0.00	36,618	0	377,239	Feb 14 06:36 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 12 '24	Option Exercise	0.00	5,736	0	15,678	Feb 14 06:36 PM
Decker Robert J	VP Corporate Controller	Feb 12 '24	Option Exercise	0.00	1,912	0	19,269	Feb 14 06:36 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 12 '24	Option Exercise	0.00	13,813	0	89,014	Feb 14 06:36 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 09 '24	Option Exercise	90.44	130,969	11,844,836	439,283	Feb 13 05:18 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 09 '24	Option Exercise	90.44	59,397	5,371,865	200,813	Feb 12 07:25 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 08 '24	Option Exercise	0.00	3,739	0	143,329	Feb 12 07:25 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 09 '24	Sale	156.27	59,397	9,281,969	141,416	Feb 12 07:25 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 08 '24	Option Exercise	0.00	5,225	0	310,583	Feb 12 07:25 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 08 '24	Option Exercise	0.00	1,971	0	67,905	Feb 12 07:25 PM
Wolk Joseph J	Exec VP, CFO	Feb 08 '24	Option Exercise	0.00	3,686	0	53,911	Feb 12 07:25 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 08 '24	Option Exercise	0.00	979	0	6,463	Feb 12 07:24 PM
Swanson James D.	See Remarks	Feb 08 '24	Option Exercise	0.00	1,868	0	11,111	Feb 12 07:24 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 08 '24	Option Exercise	0.00	1,964	0	10,943	Feb 12 07:24 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 08 '24	Option Exercise	0.00	2,135	0	104,465	Feb 12 07:24 PM
Hait William	See Remarks	Feb 08 '24	Option Exercise	0.00	3,059	0	34,497	Feb 12 07:24 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 08 '24	Option Exercise	0.00	1,880	0	21,083	Feb 12 07:24 PM
Decker Robert J	VP Corporate Controller	Feb 08 '24	Option Exercise	0.00	655	0	17,572	Feb 12 07:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JNJ

Johnson & Johnson

Upgrade your FINVIZ experience